PREDNISOLONE SODIUM PHOSPHATE | A076913 | PHARMACEUTICAL ASSOC INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lowenstein Sandler on behalf of PAI Holdings, LLC dba P... FDA-2026-P-7013 · 2 docket documents Lowenstein Sandler, on behalf of PAI Holdings, LLC (doing business as Pharmaceutical Associates, Inc. and PAI Pharma), filed this citizen petition requesting that FDA investigate the stability and safety of Kesin Pharma's repackaged Prednisolone Sodium Phosphate Oral Solution unit-dose cups stored a | 505(q) | 2026-06-24 | Open | PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1064
per ml
Lowest NADAC/Unit
$0.1064
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00121075908PREDNISOLONE 15 MG/5 ML SOLN | $0.1064 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.